Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy

Core Viewpoint - Royal Philips has announced the expanded commercial availability of LumiGuide 3D Device Guidance, the first real-time AI-enabled light-based 3D navigation solution for image-guided therapy, across Europe and the United States, marking a significant advancement in radiation-free navigation technology [1][15]. Group 1: Product Features and Benefits - LumiGuide utilizes light instead of X-ray for navigation, allowing physicians to visualize and guide devices inside the body in real-time and in 3D, significantly reducing radiation exposure for both patients and clinical staff [4][12]. - The technology enables complex procedures, such as aortic repairs, to be performed 37% faster and with up to 56% reduction in dose area product (DAP) [4]. - LumiGuide integrates seamlessly with Philips' Azurion platform, enhancing procedural innovation and efficiency across various clinical domains [2][7]. Group 2: Clinical Impact and Adoption - Over 2,000 clinical procedures have utilized LumiGuide, demonstrating its effectiveness in improving efficiency and reducing procedure time [8]. - Clinicians have reported that LumiGuide reduces time spent on fluoroscopy to near zero, enhancing overall procedural safety [3]. - The commercial rollout is set to begin in January 2026, following a successful limited market release in late 2023, expanding access to advanced image-guided therapy [8][12]. Group 3: Company Commitment and Leadership - Philips is committed to advancing radiation safety in image-guided therapy, with LumiGuide being part of a broader portfolio aimed at reducing or eliminating radiation exposure during procedures [9]. - The company emphasizes its leadership in low- and no-dose interventional solutions, reinforcing its dedication to making image-guided therapy safer and more efficient [9]. - Philips continues to invest in clinical evidence generation to optimize the use of LumiGuide in everyday practice, further solidifying its position in the health technology sector [8].